Literature DB >> 22945489

Thrombotic microangiopathy: E. coli O104:H4 German outbreak: a missed opportunity.

Piero Ruggenenti1, Giuseppe Remuzzi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22945489     DOI： 10.1038/nrneph.2012.194

Source DB:  PubMed          Journal:  Nat Rev Nephrol        ISSN： 1759-5061            Impact factor:   28.314


× No keyword cloud information.
  9 in total

1.  Clinical experiences in Sakai City Hospital during the massive outbreak of enterohemorrhagic Escherichia coli O157 infections in Sakai City, 1996.

Authors:  H Fukushima; T Hashizume; Y Morita; J Tanaka; K Azuma; Y Mizumoto; M Kaneno; M Matsuura; K Konma; T Kitani
Journal:  Pediatr Int       Date:  1999-04       Impact factor: 1.524

2.  A German outbreak of haemolytic uraemic syndrome.

Authors:  Piero Ruggenenti; Giuseppe Remuzzi
Journal:  Lancet       Date:  2011-08-24       Impact factor: 79.321

3.  Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study.

Authors:  Martina Bielaszewska; Alexander Mellmann; Wenlan Zhang; Robin Köck; Angelika Fruth; Andreas Bauwens; Georg Peters; Helge Karch
Journal:  Lancet Infect Dis       Date:  2011-06-22       Impact factor: 25.071

4.  The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.

Authors:  S Dundas; W T Todd; A I Stewart; P S Murdoch; A K Chaudhuri; S J Hutchinson
Journal:  Clin Infect Dis       Date:  2001-09-05       Impact factor: 9.079

5.  Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany.

Authors:  Christina Frank; Dirk Werber; Jakob P Cramer; Mona Askar; Mirko Faber; Matthias an der Heiden; Helen Bernard; Angelika Fruth; Rita Prager; Anke Spode; Maria Wadl; Alexander Zoufaly; Sabine Jordan; Markus J Kemper; Per Follin; Luise Müller; Lisa A King; Bettina Rosner; Udo Buchholz; Klaus Stark; Gérard Krause
Journal:  N Engl J Med       Date:  2011-06-22       Impact factor: 91.245

6.  Characteristics of the enteroaggregative Shiga toxin/verotoxin-producing Escherichia coli O104:H4 strain causing the outbreak of haemolytic uraemic syndrome in Germany, May to June 2011.

Authors:  F Scheutz; E Møller Nielsen; J Frimodt-Møller; N Boisen; S Morabito; R Tozzoli; J P Nataro; A Caprioli
Journal:  Euro Surveill       Date:  2011-06-16

7.  Enteroaggregative Escherichia coli from humans and animals differ in major phenotypical traits and virulence genes.

Authors:  Ana Paula Uber; Luiz R Trabulsi; Kinue Irino; Lothar Beutin; Angela C R Ghilardi; Tânia A T Gomes; Ana Maria A Liberatore; Antônio F P de Castro; Waldir P Elias
Journal:  FEMS Microbiol Lett       Date:  2006-03       Impact factor: 2.742

Review 8.  Hemolytic uremic syndrome.

Authors:  Marina Noris; Giuseppe Remuzzi
Journal:  J Am Soc Nephrol       Date:  2005-02-23       Impact factor: 10.121

9.  Validation of treatment strategies for enterohaemorrhagic Escherichia coli O104:H4 induced haemolytic uraemic syndrome: case-control study.

Authors:  Jan Menne; Martin Nitschke; Robert Stingele; Mariam Abu-Tair; Jan Beneke; Jörn Bramstedt; Jan P Bremer; Reinhard Brunkhorst; Veit Busch; Reinhard Dengler; Günther Deuschl; Klaus Fellermann; Helmut Fickenscher; Christoph Gerigk; Alexander Goettsche; Jobst Greeve; Carsten Hafer; Friedrich Hagenmüller; Hermann Haller; Stefan Herget-Rosenthal; Bernd Hertenstein; Christina Hofmann; Melanie Lang; Jan T Kielstein; Ulrich C Klostermeier; Johannes Knobloch; Markus Kuehbacher; Ulrich Kunzendorf; Hendrik Lehnert; Michael P Manns; Tobias F Menne; Tobias N Meyer; Claus Michael; Thomas Münte; Christine Neumann-Grutzeck; Jens Nuernberger; Hermann Pavenstaedt; Leyla Ramazan; Lutz Renders; Jonas Repenthin; Wolfgang Ries; Axel Rohr; Lars Christian Rump; Ola Samuelsson; Friedhelm Sayk; Bernhard M W Schmidt; Sabine Schnatter; Harald Schöcklmann; Stefan Schreiber; Cay U von Seydewitz; Jürgen Steinhoff; Sylvia Stracke; Sebastian Suerbaum; Andreas van de Loo; Martin Vischedyk; Karin Weissenborn; Peter Wellhöner; Monika Wiesner; Sebastian Zeissig; Jürgen Büning; Mario Schiffer; Tanja Kuehbacher
Journal:  BMJ       Date:  2012-07-19
  9 in total
  7 in total

1.  Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic Syndrome.

Authors:  Simona Buelli; Monica Locatelli; Claudia Elisa Carminati; Daniela Corna; Domenico Cerullo; Barbara Imberti; Luca Perico; Maurizio Brigotti; Mauro Abbate; Carlamaria Zoja; Ariela Benigni; Giuseppe Remuzzi; Marina Morigi
Journal:  Cells       Date:  2022-05-26       Impact factor: 7.666

Review 2.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

Review 3.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

4.  Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Authors:  Monica Locatelli; Simona Buelli; Anna Pezzotta; Daniela Corna; Luca Perico; Susanna Tomasoni; Daniela Rottoli; Paola Rizzo; Debora Conti; Joshua M Thurman; Giuseppe Remuzzi; Carlamaria Zoja; Marina Morigi
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

5.  Protective effect of oral administration of transgenic tobacco seeds against verocytotoxic Escherichia coli strain in piglets.

Authors:  Luciana Rossi; Vittorio Dell'Orto; Simona Vagni; Vittorio Sala; Serena Reggi; Antonella Baldi
Journal:  Vet Res Commun       Date:  2013-11-19       Impact factor: 2.459

Review 6.  Shiga toxins and the pathophysiology of hemolytic uremic syndrome in humans and animals.

Authors:  Chad L Mayer; Caitlin S Leibowitz; Shinichiro Kurosawa; Deborah J Stearns-Kurosawa
Journal:  Toxins (Basel)       Date:  2012-11-08       Impact factor: 4.546

7.  Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab.

Authors:  Yahsou Delmas; Benoît Vendrely; Benjamin Clouzeau; Hiba Bachir; Hoang-Nam Bui; Adeline Lacraz; Sébastien Hélou; Cécile Bordes; Armel Reffet; Brigitte Llanas; Sophie Skopinski; Patrick Rolland; Didier Gruson; Christian Combe
Journal:  Nephrol Dial Transplant       Date:  2013-11-28       Impact factor: 5.992
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.